Vidhi Specialty

Why is Vidhi Specialty Food Ingredients Ltd falling/rising?

As of 04-Aug, Vidhi Specialty Food Ingredients Ltd's stock price is Rs 331.00, down 2.86% after a trend reversal. The stock has underperformed its sector and shows declining investor participation, with a year-to-date decline of 5.31%.

As of 04-Aug, Vidhi Specialty Food Ingredients Ltd's stock price is falling, currently at Rs 331.00, which reflects a decrease of Rs 9.75 or 2.86%. This decline follows a trend reversal after three consecutive days of gains. Additionally, the stock has underperformed its sector by 1.45% today. The stock reached an intraday low of Rs 330.35, marking a decrease of 3.05%.<BR><BR>Investor participation appears to be declining, as evidenced by a significant drop in delivery volume, which fell by 48.35% compared to the 5-day average. Despite the stock trading above its moving averages for 5, 20, 50, 100, and 200 days, the overall performance year-to-date shows a decline of 5.31%, contrasting with a broader market decline of 7.97%. Over the past year, the stock has decreased by 17.09%, while the Sensex has only fallen by 3.20%. These factors collectively indicate that the stock is currently experiencing downward pressure.

Which are the latest news on Vidhi Specialty?

Are Vidhi Specialty Food Ingredients Ltd latest results good or bad?

Vidhi Specialty Food Ingredients Ltd reported strong quarterly net sales and profit growth, with net sales up 66.42% year-on-year. However, concerns over margin compression led to a 3.68% decline in stock price, indicating potential challenges in sustaining this growth.

Vidhi Specialty Food Ingredients Ltd's latest results present a mixed picture. On one hand, the company reported impressive quarterly net sales of ₹146.28 crores for Q1 FY27, which is a significant sequential growth of 19.24% compared to the previous quarter and a remarkable 66.42% increase year-on-year. Additionally, net profit rose by 34.80% to ₹17.12 crores.<BR><BR>However, despite these strong revenue and profit figures, the stock experienced a decline of 3.68% following the results announcement, closing at ₹300.65. This drop can be attributed to concerns over margin compression. The operating margin fell to 17.78%, down 556 basis points from the previous year, indicating that the company's aggressive growth may be impacting its pricing power and operational efficiency. Similarly, the profit after tax (PAT) margin also decreased to 11.70%, reflecting a deterioration in profitability metrics.<BR><BR>In summary, while the revenue growth is commendable, the significant margin compression raises concerns about the sustainability of this growth and the company's competitive positioning. Investors may need to weigh these factors carefully when assessing the overall performance of Vidhi Specialty Food Ingredients Ltd.

Should I buy, sell or hold Vidhi Specialty Food Ingredients Ltd?

When is the next results date for Vidhi Specialty Food Ingredients Ltd?

The next results date for Vidhi Specialty Food Ingredients Ltd is July 29, 2026.

The next results date for Vidhi Specialty Food Ingredients Ltd is scheduled for July 29, 2026.

How big is Vidhi Specialty?

As of 10th June, Vidhi Specialty Food Ingredients Ltd has a market capitalization of 1,438.00 Cr, with recent net sales of 380.02 Cr and a net profit of 48.83 Cr.

As of 10th June, Vidhi Specialty Food Ingredients Ltd has a market capitalization of 1,438.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 380.02 Cr and a Net Profit of 48.83 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 301.09 Cr and Total Assets of 396.06 Cr.

Who are in the management team of Vidhi Specialty?

The management team of Vidhi Specialty includes Bipin M Manek (Chairman & Managing Director), Mihir B Manek (Joint Managing Director), Pravina B Manek, Vijay K Atre, Vidhi Harsh Parekh, and Priyanka Soni, along with independent directors such as Prafulchandra A Shah and Niren D Desai. This team is responsible for the company's strategic direction and operations.

The management team of Vidhi Specialty includes the following key members:<BR><BR>1. **Bipin M Manek** - Chairman & Managing Director<BR>2. **Mihir B Manek** - Joint Managing Director<BR>3. **Pravina B Manek** - Director<BR>4. **Vijay K Atre** - Director<BR>5. **Vidhi Harsh Parekh** - Whole-time Director<BR>6. **Priyanka Soni** - Company Secretary<BR>7. **Vishakha Pandya** - Company Secretary & Compliance Officer<BR><BR>Additionally, the board includes several independent directors:<BR>- **Prafulchandra A Shah**<BR>- **Niren D Desai**<BR>- **Rahul Berde**<BR>- **Ashit Kantilal Doshi**<BR>- **Jyoti Sunil Modi**<BR><BR>This team plays a crucial role in guiding the company's strategic direction and overseeing its operations.

Who are the peers of the Vidhi Specialty?

Vidhi Specialty's peers include NOCIL, Camlin Fine, Bhansali Engg., Titan Biotech, S H Kelkar & Co., Indokem, Nitta Gelatin, Platinum Industr, Excel Industries, and Paushak. Management risk varies from excellent to below average among peers, with Titan Biotech showing the highest 1-year return at 412.73% and Camlin Fine the lowest at -57.53%.

Peers: The peers of Vidhi Specialty are NOCIL, Camlin Fine, Bhansali Engg., Titan Biotech, S H Kelkar & Co., Indokem, Nitta Gelatin, Platinum Industr, Excel Industries, and Paushak.<BR><BR>Quality Snapshot: Excellent management risk is observed at NOCIL, Bhansali Engg., Titan Biotech, Nitta Gelatin, Platinum Industr, Excel Industries, and Paushak, while Average management risk is found at Vidhi Specialty, S H Kelkar & Co., and the rest. Below Average management risk is noted at Camlin Fine and Indokem. Growth is classified as Below Average for NOCIL, Camlin Fine, Bhansali Engg., Titan Biotech, S H Kelkar & Co., Vidhi Specialty, and the rest, while Average growth is seen at Indokem and Nitta Gelatin. Excellent capital structure is present in NOCIL, Bhansali Engg., Titan Biotech, Nitta Gelatin, Platinum Industr, Excel Industries, and Paushak, while Average capital structure is found at S H Kelkar & Co., and Below Average at Camlin Fine and Indokem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Titan Biotech at 412.73%, while Camlin Fine has the lowest at -57.53%. Vidhi Specialty's own 1-year return is -31.92%, which is higher than Camlin Fine's but lower than Titan Biotech's. Additionally, the six-month return is negative for S H Kelkar & Co., Indokem, Platinum Industr, and Excel Industries.

What does Vidhi Specialty do?

Vidhi Specialty Food Ingredients Ltd manufactures and trades synthetic food colors and chemicals, categorized as a small-cap company with a market cap of INR 1,438 Cr. As of March 2026, it reported net sales of 123 Cr and a net profit of 13 Cr.

Overview: <BR>Vidhi Specialty Food Ingredients Ltd is engaged in the manufacturing and trading of synthetic food colors and chemicals within the specialty chemicals industry, categorized as a small-cap company.<BR><BR>History: <BR>The company was incorporated on 19th January, 1994, and was formerly known as Vidhi Dyestuffs Manufacturing Limited. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 123 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 13 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 1,438 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 29.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 1.58% <BR>Debt-Equity: 0.11 <BR>Return on Equity: 14.89% <BR>Price to Book: 4.33 <BR><BR>Contact Details: <BR>Address: E/27 Commerce Centre, 78 Tardeo Road Mumbai Maharashtra : 400034 <BR>Tel: 91-022-61406666 <BR>Email: info@vidhifood.com <BR>Website: http://www.vidhifoodcolours.com

Is Vidhi Specialty technically bullish or bearish?

As of December 2, 2025, Vidhi Specialty's technical trend has shifted to a bearish stance with moderate strength, driven by bearish signals from daily moving averages and monthly MACD, despite some mildly bullish indicators on the weekly timeframe.

As of 2 December 2025, the technical trend for Vidhi Specialty has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the bearish signals from the daily moving averages and the monthly MACD, which is also bearish. The weekly Bollinger Bands confirm a bearish trend, while the Dow Theory indicates a mildly bearish stance on the weekly timeframe. Despite some mildly bullish signals from the weekly MACD and KST, the overall technical picture remains negative.

Has Vidhi Specialty declared dividend?

Vidhi Specialty Food Ingredients Ltd has declared a 150% dividend, with an ex-date of November 14, 2025. While the dividend yield is 1.58%, total returns have been mixed, showing negative performance in shorter periods but a strong positive return of 176.37% over five years.

Vidhi Specialty Food Ingredients Ltd has declared a 150% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 150%<BR>- Ex-date: 14 Nov 25<BR><BR>Dividend Yield: 1.58%.<BR><BR>Total Returns by Period:<BR>In the 3 Months period, the price return was -10.33%, the dividend return was 0.78%, resulting in a total return of -9.55%.<BR><BR>In the 6 Months period, the price return was -25.4%, the dividend return was 1.02%, leading to a total return of -24.38%.<BR><BR>For the 1 Year period, the price return was -29.31%, the dividend return was 1.44%, culminating in a total return of -27.87%.<BR><BR>During the 2 Years period, the price return was -19.5%, the dividend return was 2.16%, resulting in a total return of -17.34%.<BR><BR>In the 3 Years period, the price return was -9.22%, the dividend return was 2.81%, leading to a total return of -6.41%.<BR><BR>For the 4 Years period, the price return was -0.1%, the dividend return was 3.34%, resulting in a total return of 3.24%.<BR><BR>In the 5 Years period, the price return was 166.88%, the dividend return was 9.49%, culminating in a total return of 176.37%.<BR><BR>Overall, while Vidhi Specialty has declared a significant dividend, the total returns over various periods show a mixed performance, with negative returns in the shorter terms but a strong positive return over the five-year period.

How has been the historical performance of Vidhi Specialty?

Vidhi Specialty's historical performance has shown fluctuations, with net sales peaking at 537.05 Cr in Mar'22 before declining to 382.30 Cr in Mar'25, while profitability metrics like operating profit and profit after tax also decreased during this period. Despite growth in total assets from 186.37 Cr in Mar'20 to 396.06 Cr in Mar'25, cash flow from operating activities turned negative in Mar'25.

Answer:<BR>The historical performance of Vidhi Specialty shows fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vidhi Specialty's net sales have varied significantly, with a peak of 537.05 Cr in Mar'22, followed by a decline to 382.30 Cr in Mar'25. The total operating income mirrored this trend, reaching 403.99 Cr in Mar'23 before dropping to 382.30 Cr in Mar'25. The company's total expenditure, excluding depreciation, was highest in Mar'22 at 452.45 Cr, but decreased to 313.83 Cr in Mar'25. Operating profit, which peaked at 84.60 Cr in Mar'22, fell to 68.47 Cr in Mar'25, while profit before tax showed a similar decline from 78.96 Cr in Mar'22 to 59.99 Cr in Mar'25. Profit after tax also decreased from 58.57 Cr in Mar'22 to 43.40 Cr in Mar'25. On the balance sheet, total assets increased from 186.37 Cr in Mar'20 to 396.06 Cr in Mar'25, with total liabilities also rising from 186.37 Cr to 396.06 Cr in the same period. The cash flow from operating activities turned negative in Mar'25 at -4.00 Cr, contrasting with a positive cash flow of 71.00 Cr in Mar'24. Overall, while Vidhi Specialty has seen growth in assets and some recovery in sales, profitability metrics have shown a downward trend in recent years.

Who are the top shareholders of the Vidhi Specialty?

The top shareholders of Vidhi Specialty include the Pravinamanek Family Private Trust with 26.03%, individual investors with 27.29%, and Mukul Mahavir Agrawal as the largest public shareholder at 1.6%. Additionally, 13 Foreign Institutional Investors hold a combined 0.11%, and no mutual funds currently own shares.

The top shareholders of Vidhi Specialty include the promoters, who hold the majority of the shares. The promoter with the highest holding is the Pravinamanek Family Private Trust, which owns 26.03% of the company. Additionally, individual investors collectively hold 27.29% of the shares. In terms of public shareholders, Mukul Mahavir Agrawal is the highest with a holding of 1.6%. There are also 13 Foreign Institutional Investors (FIIs) that hold a combined 0.11% of the shares, while no mutual funds currently hold shares in the company.

Is Vidhi Specialty overvalued or undervalued?

As of May 31, 2023, Vidhi Specialty is considered very expensive and overvalued with a PE ratio of 48.06, significantly higher than its peers, and has underperformed the Sensex with a year-to-date return of -19.10%.

As of 31 May 2023, the valuation grade for Vidhi Specialty has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued, with a PE ratio of 48.06, a Price to Book Value of 6.93, and an EV to EBITDA of 31.06. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Vidhi Specialty's PE ratio is notably higher than Sudarshan Chemicals, which has a PE of 71.32, and significantly above Kiri Industries, which stands at 13.72. This disparity highlights the overvaluation of Vidhi Specialty within the specialty chemicals sector. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -19.10% compared to the Sensex's 5.59%, further reinforcing the notion that the stock is overvalued.